LITRON LABORATORIES LTD: public contracts won without a rival in Canada: 6 uncontested awards; 100% of its awards; 6 without a competition; 0 single bid.
Assay record ASY-CA-03Y32B414D · Cite as: Assay Systems, “LITRON LABORATORIES LTD: public contracts won without a rival in Canada”, https://assay-systems.com/register/ca/uncontested/s/litron-laboratories-ltd/
LITRON LABORATORIES LTD won 6 of its 6 public contract awards in Canada without a rival from 2022-01-05 to 2026-02-17, worth $147K: 6 without a competition and 0 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Health Canada with 6.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
Health Canada gave LITRON LABORATORIES LTD 6 awards: 6 without a competition, 0 after a competition with a single bid. First 2022-01-05, latest 2026-02-17.
| Date | Buyer | How | Value | Stated reason |
|---|---|---|---|---|
| 2026-02-17 | Health Canada C-2025-2026-Q4-00297 | No competition TN | $79.9K | 00 |
| 2025-12-02 | Health Canada C-2025-2026-Q3-00316 | No competition TN | $19.4K | 00 |
| 2025-10-28 | Health Canada C-2025-2026-Q3-00167 | No competition TN | $22.3K | 00 |
| 2022-08-15 | Health Canada C-2022-2023-Q2-00236 | No competition TN | $23.9K | 00 |
| 2022-04-27 | Health Canada C-2022-2023-Q1-00215 | No competition TN | $16.0K | 00 |
| 2022-01-05 | Health Canada C-2021-2022-Q4-00173 | No competition TN | $39.8K | 00 |
Every uncontested award in Canada · All countries · LITRON LABORATORIES LTD in the register
Source: Government of Canada proactive disclosure of contracts over $10,000 (open.canada.ca), Open Government Licence – Canada. Awards are matched to their buyer and supplier as published. Updated 17 October 2026.